Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleResponse to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”.AuthorsKazerooni, Rashid; Armstrong, Edward P.PublicationClinical Drug Investigation, 2018, Vol 38, Issue 12, p1199ISSN1173-2563Publication typeLetter to the EditorDOI10.1007/s40261-018-0724-3